COVID-19 vaccination in Greece

Last updated
COVID-19 vaccination in Greece
Native name Εθνική Εκστρατεία Εμβολιασμού «Επιχείρηση Ελευθερία»
Date27 December 2020 (2020-12-27) – present
LocationNationwide
Cause COVID-19 pandemic
TargetFull immunisation of people in Greece against COVID-19
Participants12.558.035 doses administered
(24 October 2021)
6,593,449 have received at least one vaccine dose (24 October 2021)
61.7%
6,341,166 have received both vaccine doses(24 October 2021)
59.3%
Website Official Website

The COVID-19 vaccination campaign in Greece began on 27 December 2020. [1] As of the 24th of October 2021, 6,593,449 people have received their first dose (61.7% of total population), and 6,341,166 people have been fully vaccinated (59.3% of total population). [2]

Vaccines on order

There are several COVID-19 vaccines at various stages of development around the world.

VaccineApprovalDeployment
Pfizer–BioNTech Green check.svg 21 December 2020Green check.svg 27 December 2020
Moderna Green check.svg 6 January 2021Green check.svg 12 January 2021
Oxford-AstraZeneca Green check.svg 29 January 2021Green check.svg 7 February 2021
Janssen Green check.svg 11 March 2021Green check.svg 5 May 2021

Related Research Articles

COVID-19 vaccination in Sweden

Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden, the Public Health Agency has been commissioned by the government to create a vaccination plan. Sveriges riksbank, the central bank of Sweden, predicts that efficient vaccination against COVID-19 has macroeconomic benefits. As of 1 September 2021, 82.0% of adults in Sweden have received at least one dose, with a total of 12,700,896 administered.

COVID-19 vaccination in India Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 24 October 2021, India has administered over 1.02 billion doses overall, including first and second doses of the currently-approved vaccines. In India, nearly half the eligible population has got at least one shot, and 19 per cent received both nine months after the vaccine rollout.

COVID-19 vaccination in Albania

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

COVID-19 vaccination in Malaysia

The National COVID-19 Immunisation Programme, abbreviated as NIP or PICK, is a national vaccination campaign that is currently being implemented by the Malaysian government as an approach in curbing the spread of coronavirus disease 2019 (COVID-19) and to end the COVID-19 pandemic in Malaysia by successfully achieving the herd immunity among its citizens and non-citizens that are residing in Malaysia. It is the largest immunisation programme implemented in the history of the country and it is being administrated by The Special Committee For Ensuring Access To COVID-19 Vaccine Supply (JKJAV) since early 2021.

COVID-19 vaccination in Russia

The COVID-19 vaccination campaign in Russia is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Mass vaccinations began in December 2020, starting with primarily doctors, medical workers and teachers, and in January 2021, this was extended to the entire population.

COVID-19 vaccination in Zimbabwe

On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using BBIBP-CorV. As of 24 October 2021, 3,268,655 people have received their first dose, and 2,539,524 people have received their second dose.

On 29 January 2021, Algeria launched a coronavirus vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

On 23 February 2021, Senegal began its national vaccination program against the COVID-19. As of 10 March, 68,205 people in Senegal have been able to be vaccinated.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Bhutan

Bhutan has promised a free COVID-19 vaccination to all of its citizens, both inside and outside the country. It started mass vaccinations on 27 March 2021.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Croatia Plan to immunize against COVID-19

During the COVID-19 pandemic in Croatia, vaccination against COVID-19 began on 27 December 2020. The Croatian government ordered vaccines together with the EU. 8.7 million doses have been ordered. As of 21 October 2021, 1,763,617 people were fully vaccinated, corresponding to a 43.5% vaccination rate of the country's population.

The COVID-19 vaccination campaign in Quebec is an ongoing provincial effort to distribute and administer the vaccine against COVID-19.

COVID-19 vaccination in Nigeria Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 8 October 2021, 5,118,422 people have received their first dose a COVID-19 vaccine, and 2,359,781 people have received their second dose.

COVID-19 vaccination in Germany

The COVID-19 vaccination campaign in Germany began on 26 December 2020. As of 19 September 2021, 55,869,314 people have received at least one dose, while 52,503,166 people have been fully vaccinated.

COVID-19 vaccination in Singapore Plan to immunize against COVID-19

COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 22 October 2021, Singapore has administrated a total of 9,752,204 doses under its national vaccination programme.

COVID-19 vaccination in Iceland is an effort to immunize the adult population of Iceland due to the COVID-19 pandemic. As of July 2021, more than 260,000 individuals have received at least one dose of COVID-19 vaccine, which is over 78% of the country's population. The vaccines approved for use in Iceland are Pfizer, Moderna, AstraZeneca, Janssen. Iceland has also signed a contract with CureVac.

COVID-19 vaccination in Spain Immunization plan against COVID-19 in Spain

The COVID-19 vaccination in Spain is the national vaccination strategy started on the 27th of December 2020 in order to vaccinate the country's population against COVID-19 within the international effort to fight the COVID-19 pandemic.

COVID-19 vaccination in Ukraine

The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.

References

  1. Newsroom. "Γεγονός οι πρώτοι εμβολιασμοί στην Ελλάδα κατά της Covid-19 | Η ΚΑΘΗΜΕΡΙΝΗ". www.kathimerini.gr. Retrieved 2021-04-11.
  2. "COVID-19 vaccination statistics". www.data.gov.gr. Retrieved 2021-04-25.